Cidara Therapeutics Inc expected to post a loss of $4.10 a share - Earnings Preview

Cidara Therapeutics

30/07/2024 15:56

* Cidara Therapeutics Inc  CDTX.OQ   CDTX.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 1
(estimated) for the period ending June 30 2024
    * The San Diego California-based  company is expected to
report a
38.3% decrease in revenue to $4.7 million from $7.61 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Cidara Therapeutics Inc
is for
a loss of $4.10 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cidara
Therapeutics Inc is $40.00​, above​ its last closing price
of $13.05. ​​​

This summary was machine generated July 30 at 14:56 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)